Medical Bulletin 04/August/2025 Dr. Bhumika Maikhuri4 Aug 2025 4:12 PM ISTHere are the top medical news for the day:Shedding Weight, Losing Muscle: Study Links GLP-1 Drugs to Reduced Mass MusclePopular weight-loss...
37 Essential Drugs Including Paracetamol, Atorvastatin To Get Cheaper, NPPA Issues Revised Price List Farhat Nasim4 Aug 2025 3:00 PM ISTNew Delhi: Through a recent Gazette notification, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and...
High-Potency Statins Found Most Effective in Lowering Bad Cholesterol: Study Dr. Bhumika Maikhuri4 Aug 2025 8:15 AM ISTNew research published in Trends in Cardiovascular Medicine emphasizes the importance of aggressively lowering LDL cholesterol with high-dose statins...
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval, Atorvastatin patent filing Ruchika Sharma11 Dec 2024 10:00 AM ISTMumbai: Supriya Lifescience Ltd. has acquired approval from Brazil's health authority, ANVISA (Agência Nacional de Vigilância Sanitária), for...
NPPA Hikes Price of Cholesterol-Lowering Drug Atorvastatin Farhat Nasim25 Nov 2024 6:23 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently revised the ceiling price of Atorvastatin 10 mg, a widely used...
Rosuvastatin has Slight Edge Over Atorvastatin in reduction of all cause mortality among patients with dislipedemia, suggests study Dr Riya Dave9 Nov 2024 8:45 AM ISTResearchers have found that while rosuvastatin and atorvastatin are two of the most commonly prescribed drugs in managing cholesterol, rosuvastatin...
Theory to Practice: Implementing Aspirin and Statin Therapy in Primary Care Settings Dr Nishant Tripathi5 Nov 2024 9:00 AM ISTPremature ASCVD in IndiaThe prevalence of atherosclerotic cardiovascular disease (ASCVD) has been increasing in India, surpassing infectious diseases...
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
Impact of Regular Aspirin Use on ASCVD Mortality in Adults with Elevated Lipoprotein(a) Levels Prof. Soumitra Kumar1 Oct 2024 12:52 PM ISTWith a rising incidence of cardiovascular disease (CVD) among younger individuals aged below 55 years(1),particularly in India, where it occurs about...
The Role of Aspirin in Reducing ASCVD Mortality Among Adults with High Lp(a) Concentrations Dr A B Chandorkar8 Aug 2024 11:00 AM ISTAtherosclerotic cardiovascular disease (ASCVD) burden in young individuals is a major health concern, particularly in less developed nations where...
Intas Pharmaceutical Gets CDSCO Panel Nod to Study Atorvastatin plus Fenofibrate FDC Dr. Divya Colin17 July 2024 5:30 PM ISTNew Delhi: The drug major Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
